Tolaney SM, Toi M, Neven P, Sohn J, et al. Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant. Clin Cancer Res 2022;28:1500-1506.
PMID: 35121623